Cargando…
Incidence of Immune Checkpoint Inhibitor-Associated Diabetes: A Meta-Analysis of Randomized Controlled Studies
Background: Immune checkpoint inhibitors (ICIs) are now an important option for more than 14 different cancers. Recent series case reports have described that ICIs are associated with new-onset diabetes in patients, yet the definitive risk is not available. We thus performed a meta-analysis of rando...
Autores principales: | Lu, Jingli, Yang, Jing, Liang, Yan, Meng, Haiyang, Zhao, Junjie, Zhang, Xiaojian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915045/ https://www.ncbi.nlm.nih.gov/pubmed/31920646 http://dx.doi.org/10.3389/fphar.2019.01453 |
Ejemplares similares
-
Immune checkpoint inhibitor‐associated pituitary‐adrenal dysfunction: A systematic review and meta‐analysis
por: Lu, Jingli, et al.
Publicado: (2019) -
Adipose Tissue-Resident Immune Cells in Obesity and Type 2 Diabetes
por: Lu, Jingli, et al.
Publicado: (2019) -
The Relative Risk and Incidence of Immune Checkpoint Inhibitors Related Pneumonitis in Patients With Advanced Cancer: A Meta-Analysis
por: Ma, Ke, et al.
Publicado: (2018) -
Immune Checkpoint Inhibitor–Associated Tumor Lysis Syndrome: A Real-World Pharmacovigilance Study
por: Wang, Li, et al.
Publicado: (2021) -
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors
por: Zou, Xue-lin, et al.
Publicado: (2021)